Construction of dual S-scheme heterojunctions g-C3N4/CoAl-LDH@MIL-53(Fe) ternary photocatalyst for enhanced photocatalytic H2 evolution
Applied Surface Science · 2025-03 · 684 · 161862
DOI: 10.1016/j.apsusc.2024.161862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Surface Science, 2025-03. Verfasst von Junqing Ye und 6 weiteren Autor:innen. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province, Changzhou University, Jiangsu Provincial Key Laboratory of Advanced Catalytic Materials and Technology Department, Jiangsu Provincial Department of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province
- Changzhou University
- Jiangsu Provincial Key Laboratory of Advanced Catalytic Materials and Technology Department, Jiangsu Provincial Department of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Ye, J., Wan, Y., Li, Y., Xu, S., Li, X., Chen, Q., & Li, X. (2025). Construction of dual S-scheme heterojunctions g-C3N4/CoAl-LDH@MIL-53(Fe) ternary photocatalyst for enhanced photocatalytic H2 evolution. Applied Surface Science, 684, 161862. https://doi.org/10.1016/j.apsusc.2024.161862
Vancouver
Ye J, Wan Y, Li Y, Xu S, Li X, Chen Q, et al. Construction of dual S-scheme heterojunctions g-C3N4/CoAl-LDH@MIL-53(Fe) ternary photocatalyst for enhanced photocatalytic H2 evolution. Applied Surface Science. 2025;684:161862. doi:10.1016/j.apsusc.2024.161862
BibTeX
@article{Ye2025,
author = {Ye, Junqing and Wan, Yiyang and Li, Yujie and Xu, Shuying and Li, Xiazhang and Chen, Qun and Li, Xibao},
title = {Construction of dual S-scheme heterojunctions g-C3N4/CoAl-LDH@MIL-53(Fe) ternary photocatalyst for enhanced photocatalytic H2 evolution},
journal = {Applied Surface Science},
year = {2025},
volume = {684},
pages = {161862},
doi = {10.1016/j.apsusc.2024.161862}
}
EUVIMED